After a few days riding a motorcycle on track again, Marc Marquez has been passed fit to ride at the Sepang MotoGP test on February 5th and 6th. The Spaniard underwent a medical check on Monday, January 24th and was given the go ahead to ride.
What is most remarkable about the press release from the Repsol Honda team is the very positive language used. The treatment route chosen, a conservative route avoiding surgery and using exercises and passive treatment instead, is described as having been "a complete success". This suggests Marquez will be at 100% fitness with regards to his vision, with only his shoulder a slight concern.
Marquez will ride the radically redesigned 2022-spec Honda RC213V at the Sepang test, alongside teammate Pol Espargaro.
The Repsol Honda press release appears below:
Repsol Honda Team confirm Marc Marquez for Sepang Test
Marc Marquez has been cleared to make his on-track return with the new Honda RC213V and the Repsol Honda Team at the Sepang Test on February 05, 2022.
Throughout the winter Marquez has had continual medical checks and consultations to monitor his diplopia. In recent weeks the improvements in his condition saw his medical team deem his recovery sufficient to return to training on two wheels. The #93 first returned to the motocross track before trying the Honda RC213V-S in Portimao and a Honda CBR600RR in Aragon.
Last Monday, January 24, Marquez underwent another medical check which reconfirmed that the treatment has been a complete success and the eight-time World Champion is in a suitable condition to ride a MotoGP bike.
Therefore, it has been decided that Marquez will start his 2022 campaign at the first official MotoGP Test in Sepang before heading to Mandalika, Indonesia the following week. This will be Marquez’s first time back on a MotoGP machine since winning the 2021 Emilia Romagna GP ahead of Pol Espargaro.
The Repsol Honda Team will head to the first test of the new season at full strength with Marquez alongside Pol Espargaro, who enters his second year with the team.